Exchange: NASDAQ·Updated 07:03 PM EST

CVAC CureVac N.V.

$4.66
$0.01
(0.21%)
Today
Closed $4.66
$0.04
(0.86%)
After Hours
Reported EarningsAug 15
Mkt Cap$1.05B
Vol1.15M

About CVAC

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
47

Neutral Sentiment

How do you feel about CVAC?

Advertisement|Remove ads.